About 50 results
Open links in new tab
  1. HER2-positive breast cancer: What is it? - Mayo Clinic

    Apr 9, 2024 · HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). This protein promotes the growth of cancer cells.

  2. Cáncer de mama positivo para HER2: ¿qué es? - Mayo Clinic

    Apr 9, 2024 · En aproximadamente 1 de cada 5 cánceres de mama, las células cancerosas tienen copias extra del gen que produce la proteína conocida como HER2. HER2 -positivo tienden a ser …

  3. Breast cancer types: What your type means - Mayo Clinic

    Oct 31, 2024 · Breast cancer types include ductal carcinoma and lobular carcinoma. Learn about these and other types of breast cancer.

  4. سرطان الثدي الإيجابي HER2: ما هو؟ - Mayo Clinic (مايو كلينك)

    مرض سرطان الثدي الإيجابي HER2 يميل إلى أن يكون أكثر شدة بكثير من أنواع أخرى من سرطان الثدي. العلاجات التي تستهدف هرمون HER2 تكون فعالة للغاية.

  5. HER2 阳性乳腺癌:这是什么病? - 妙佑医疗国际

    Apr 9, 2024 · HER2 阳性乳腺癌是一种被称为人表皮生长因子受体 2(HER2)的蛋白质检测呈阳性的乳腺癌。这种蛋白质对癌细胞的生长有促进作用。 每 5 名乳腺癌患者中大约有 1 名患者的癌细胞中含 …

  6. Invasive lobular carcinoma - Diagnosis and treatment - Mayo Clinic

    Jun 26, 2024 · Diagnosis Diagnosing invasive lobular carcinoma and other kinds of breast cancer often begins with an exam and a discussion of your symptoms. Imaging tests can look at the breast tissue …

  7. Chemotherapy for breast cancer - Mayo Clinic

    Jan 10, 2025 · HER2-positive breast cancer. Triple-negative breast cancer. High-grade breast cancers. Cancers that have spread to the lymph nodes. Larger breast cancers. Chemotherapy as the primary …

  8. Recurrent breast cancer - Symptoms and causes - Mayo Clinic

    Apr 19, 2024 · Recurrent breast cancer may occur months or years after your initial treatment. The cancer may come back in the same place as the original cancer (local recurrence), or it may spread …

  9. Breast Clinic - Clinical trials - Mayo Clinic

    Nov 7, 2025 · The purpose of this study is to determine the correlation between HER2 specific T-cell response in HER2-positive breast cancer patients with stage I-IV who receive anti-HER2 therapies, …

  10. Pertuzumab (intravenous route) - Side effects & uses - Mayo Clinic

    Jan 1, 2026 · Pertuzumab injection is used in combination with other cancer medicines (eg, trastuzumab, docetaxel) to treat HER2-positive metastatic (cancer that has spread) breast cancer in …